A Double-Blind, Randomized, Placebo Controlled Trial of Ramelteon for the Treatment of Insomnia and Mood Stability in Patients with Euthymic Bipolar Disorder

Publication/Presentation Date

2007

Abstract

The study was a single-site, double-blind, randomized, placebo-controlled, parallel group study to evaluate the efficacy of adjunctive ramelteon in the treatment of insomnia and mood stability in patients with euthymic bipolar disorder for up to 24 weeks of maintenance treatment. Participants with euthymic bipolar disorder and sleep disturbances were randomized to receive adjunctive ramelteon or placebo in addition to their reular psychiatric medications for up to 24 weeks or until they experienced a relapse (defined as a depressed or manic event).

Comments

Study completed October 2007 through August 2009

Disciplines

Health Services Research | Medicine and Health Sciences | Psychiatry

Document Type

Research

Funder

Takeda Pharmaceuticals North America, Inc.

This document is currently not available here.

Share

COinS